Extended-spectrum beta-lactamase-producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns

References

• Gómez J, García Vázquez E, Ruiz Gómez J. Clinical relevance of bacterial resistance: a historical approach (1982–2007). Rev Esp Quimioter. 2008; 21: 115–122.
   Web of Science ®Google Scholar
• Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. J Antimicrob Chemother. 2008; 62: 1142–1149. 10.1093/jac/dkn293.
   PubMed Web of Science ®Google Scholar
• Graffunder EM, Preston KE, Evans AM, Venezia R. Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother. 2005; 56: 139–145. 10.1093/jac/dki180.
   PubMed Web of Science ®Google Scholar
• Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007; 59: 165–170. 10.1093/jac/dkl483.
   PubMed Web of Science ®Google Scholar
• Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008; 13: pii: 19044.
   Google Scholar
• Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection. J Antimicrob Chemother. 2009; 63: 781–784. 10.1093/jac/dkp028.
   Web of Science ®Google Scholar
• Denholm JT, Huysmans M, Spelman D. Community acquisition of ESBL-producing Escherichia coli: a growing concern. Med J Aust. 2009; 190: 45–46.
   Web of Science ®Google Scholar
• Owens RC, Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis. 2006; 42: 173–181. 10.1086/500664.
   PubMed Web of Science ®Google Scholar
• Howard DP, Williams C, Sen S, Shah A, Daurka J, Bird R. A simple effective clean practice protocol significantly improves hand decontamination and infection control measures in the acute surgical setting. Infection. 2009; 37: 34–38. 10.1007/s15010-008-8005-3.
   Web of Science ®Google Scholar
• Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A; Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother. 2005;49:2122–5. 10.1128/AAC.49.5.2122-2125.2005.
   PubMed Web of Science ®Google Scholar
• Guembe M, Cercenado E, Alcalá L, Marín M, Insa R, Bouza E. Evolution of antimicrobial susceptibility patterns of aerobic and facultative gram-negative bacilli causing intra-abdominal infections: results from the SMART studies 2003–2007. Rev Esp Quimioter. 2008; 21: 166–173.
   Web of Science ®Google Scholar
• Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA. In vitro susceptibilities of aerobic and facultatively anaerobic gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). J Antimicrob Chemother. 2006; 58: 205–210. 10.1093/jac/dkl199.
   PubMed Web of Science ®Google Scholar
• Baquero F, Cercenado E, Cisterna R, De la Rosa M, García-Rodríguez JA, Gobernado M. Patrones de sensibilidad a antimicrobianos de Enterobacteriaceae causantes de infecciones intraabdominales en España: resultados del estudio SMART 2003. Rev Esp Quimioter. 2006; 19: 51–59.
   Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20th informational supplement. M100-S20 CLSI. Wayne PA: Clinical and Laboratory Standards Institute, 2010.
   Google Scholar
• MacKenzie FM, Miller CA, Gould IM. Comparison of screening methods for TEM and SHV-derived extended-spectrum beta-lactamase detection. Clin Microbiol Infect. 2002; 8: 715–724. 10.1046/j.1469-0691.2002.00473.x.
   PubMed Web of Science ®Google Scholar
• Drieux L, Brossier F, Sougakoff W, Jarlier V. Phenotypic detection of extended-spectrum betalactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect. 2008; 14: 90–103. 10.1111/j.1469-0691.2007.01846.x.
   PubMed Web of Science ®Google Scholar
• Wroblewska MM, Rudnicka J, Marchel H, Luczak M. Multidrug-resistant bacteria isolated from patients hospitalised in Intensive Care Units. Int J Antimicrob Agents. 2006; 27: 285–289. 10.1016/j.ijantimicag.2005.11.015.
   PubMed Web of Science ®Google Scholar
• Mulvey MR, Bryce E, Boyd D, Ofner-Agostini M, Christianson S, Simor AE. Ambler class A extended-spectrum B-lactamase producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob Agents Chemother. 2003; 48: 1204–1214. 10.1128/AAC.48.4.1204-1214.2004.
   Web of Science ®Google Scholar
• Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin Infect Dis. 2004; 39: 1835–1841. 10.1086/425744.
   PubMed Web of Science ®Google Scholar
• Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. Lancet Oncol. 2009; 10: 589–597. 10.1016/S1470-2045(09)70069-5.
   PubMed Web of Science ®Google Scholar
• Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med. 2002; 165: 1475–1479. 10.1164/rccm.2110035.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ku WC, von Guttberg A, Mohapatra S, Casellas JM, Goossens H. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis. 2003; 39: 31–37. 10.1086/420816.
   Web of Science ®Google Scholar
• Bowler PG, Duerden BI, Armstrong DG. Wound microbiology and associated approaches to wound management. Clin Microbiol. 2001; 14: 244–269. 10.1128/CMR.14.2.244-269.2001.
   PubMed Web of Science ®Google Scholar
• Owens CD, Stoessel K. Surgical site infections: epidemiology, microbiology and prevention. J Hosp Infect. 2008; 70: 3–10. 10.1016/S0195-6701(08)60017-1.
   PubMed Web of Science ®Google Scholar
• Queenan AM, Foleno B, Gownley C, Wira E, Bush K. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. J Clin Microbiol. 2004; 42: 269–275. 10.1128/JCM.42.1.269-275.2004.
   PubMed Web of Science ®Google Scholar
• Treviño M, Moldes L, Martínez-Lamas L, Varón C, Regueiro BJ. Carbapenem-resistant Enterobacter cloacae and the emergence of metallo-beta-lactamase-producing strains in a third-level hospital (Santiago de Compostela, NW Spain). Eur J Clin Microbiol Infect Dis. 2009; 28: 1253–1258. 10.1007/s10096-009-0765-x.
   PubMed Web of Science ®Google Scholar